Skip to main content
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
29.50
-0.26 (-0.87%)
At close: Jul 19, 2024, 4:00 PM
29.56
+0.06 (0.20%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Spyre Therapeutics Revenue

Spyre Therapeutics had revenue of $688.00K in the twelve months ending March 31, 2024. In the year 2023, Spyre Therapeutics had annual revenue of $886.00K.

Revenue (ttm)
$688.00K
Revenue Growth
-40.94%
P/S Ratio
2,177.44
Revenue / Employee
$22,933
Employees
30
Market Cap
1.50B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023886.00K-1.44M-61.96%
Dec 31, 20222.33M-16.41M-87.57%
Dec 31, 202118.74M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20183.89M-1.32M-25.30%
Dec 31, 20175.21M577.00K12.47%
Dec 31, 20164.63M-1.46M-23.94%
Dec 31, 20156.09M--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 3.05B
Teladoc Health 2.62B
Indivior 1.12B
Tilray Brands 743.25M
Alphatec Holdings 511.63M
InMode 466.26M
BioCryst Pharmaceuticals 355.40M
Kiniksa Pharmaceuticals 301.77M
Revenue Rankings

SYRE News

More News